Allergy is a hyper-sensitivity to a specific substance which, if inhaled, ingested, touched or injected, causes characteristic symptoms.
ALL INMUNOTEK NEWS
INMUNOTEK selected in CEPYME500 in the 2020 edition. This is an initiative of CEPYME (State Confederation of Small and Medium Enterprises) to identify, recogniz... More info
The European Patent Office has granted to INMUNOTEK the patent EP2982381B1. This refers to hypoallergenic neoglycoconjugates performed with non-oxidized mannan ... More info
INMUNOTEK obtains the CIEGE Seal for excellence in business management for the second consecutive year. This Seal certifies excellent management over 57 indicat... More info
INNOVATING AND SHARING IDEAS
From the outset, in 1992, our goal has been to offer innovative and competitive products of the highest quality, useful for professionals and safe and effective for the treatment of patients. To this end we have put together a highly professional and motivated team; we have outstanding facilities and a broad product porfolio.
Inmunotek products are approved by the Spanish Drug Agency and several international regulatory agencies and marketed in more than 50 countries all over the world.